Phoebe Joy Ho

18PUBLICATIONS
98CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 16, 2026
Toxicity-Related Treatment Cessation in Newly Diagnosed Multiple Myeloma-Risk Factors and Survival: An Analysis From the APAC and ANZ Myeloma and Related Diseases Registry.

|May 05, 2026
Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma.

|Feb 17, 2026
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Mark R Dowling, Edward Robert Scheffer Cliff, Anthony Jeffrey

|Nov 18, 2025
Five-Year Analysis of the JULIET Trial of Tisagenlecleucel in Patients With Relapsed/Refractory Large B-Cell Lymphoma.

Richard T Maziarz, Michael R Bishop, Constantine S Tam

|Aug 05, 2025
Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7 and DREAMM-8 trials.

María-Victoria Mateos, Suzanne Trudel, Hang Quach

|Aug 05, 2025
Management of patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplantation: position statement of the Medical and Scientific Advisory Group of Myeloma Australia.

Georgia McCaughan, Hayley Beer, Christian Bryant

Pageof 3

Frequent Collaborators

5 joint publications

Elizabeth Moore

5 joint publications

Hang Quach

5 joint publications

Simon James Harrison

5 joint publications

Andrew Spencer